77
COVID-19 Tanı

1. Zhou P, Yang X Lou, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar 12;579(7798):270–3.
2. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar 12;579(7798):265–9.
3. Kuşkucu MA, Midilli K. COVID-19 patogenezi ve tanıda kullanılan serolojik ve moleküler testler. Yiğit Ö, editör. Kulak Burun Boğaz ve COVID-19. 1. Baskı. Ankara: Türkiye Klinikleri; 2020.
p.9-15.
4. Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: virology, biology and novel laboratory diagnosis. J Gene Med 2021;23:e3303.
5. Kuşkucu MA, COVID-19 Pathogenesis and Diagnosis, Cam and Sakura Med J 2022;2(Suppl 1):6-13.
6. Rai P, Kumar BK, Deekshit VK, et al. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol 2021;105:441-455.
7. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Vol. 323, JAMA – Journal of the American Medical Association. American
Medical Association; 2020. p. 1843–4.
8. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-422. Erratum in: Lancet Respir Med 2020.
9. Kashani NR, Azadbakht J, Ehteram H, et al. Molecular and clinical investigation of COVID-19: from pathogenesis and immune responses to novel diagnosis and treatment. Front Mol Biosci
2022;9:770775.
10. Afzal A. Molecular diagnostic technologies for COVID-19: limitations and challenges. J Adv Res 2020;26:149-159.
11. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses. Vol. 14, Nature Reviews Microbiology. Nature Publishing Group; 2016.
p. 523–34.
12. Vashist SK. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends. Diagnostics. 2020;10(4):202. Available from: https://www.mdpi.com/2075-4418/10/4/202
13. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020;10:102-108.
14. Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol 2020;58:e00512-e00520.
15. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, et al. Diagnosing COVID-19: The Disease and Tools for Detection. Vol. 14, ACS nano. NLM (Medline); 2020.
p. 3822–35.
16. Diao B, Wen K, Chen J, Liu Y, Yuan Z, Han C, et al. Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein. medRxiv. 2020 Mar
13;2020.03.07.20032524.
17. Reynard C, Allen JA, Shinkins B, et al. COVID-19 rapid diagnostics: practice review. Emerg Med J 2022;39:70-76.
18. Khalid MF, Selvam K, Jeffry AJN, et al. Performance of rapid antigen tests for COVID-19 diagnosis: a systematic review and meta-analysis. Diagnostics (Basel) 2022;12:110.
19. Li D, Li J. Immunologic testing for SARS-CoV-2 infection from the antigen perspective. J Clin Microbiol 2021;59:e02160-e02220.
20. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020;25:2000045.
21. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany (pdf) Available from: https://www.who.int/nepal/activities/supporting-elimination-of-ka-
la-azar-as-a-public-health-problem/docs/default-source/coronaviruse/protocol-v2-1
22. Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant, Elsevier Enhanced Reader Available from: ht-
tps://reader.elsevier.com/reader/sd/pii/S1386653221000810?token=C1885EC51F970AB8AE21 70C5252FC400B1CB7CD40F731832CDD6A9168D31A0CE766AE6816C22EEEB-
0D0C7C336362273B &originRegion=eu-west-1&originCreation=20210514142047
23. Filkins L, SoRelle JA, Schoggins J, Park JY. Laboratory Action Plan for Emerging SARS-CoV-2 Variants. Clin Chem [Internet]. 2021 Apr 29 [cited 2021 May 14];67(5):720–3. Available from:
https://academic.oup.com/clinchem/article/67/5/720/6124354
24. Wang H, Jean S, Eltringham R, Madison J, Tu H, Jones DM, et al. Title: Mutation-specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identifica-
tion of a Newly Emerging Variant with Spike 2 L452R Mutation. 2021; Available from: https://doi.org/10.1101/2021.04.22.21255574
25. Pu R, Liu S, Ren X, et al. The screening value of RT-LAMP and RT-PCR in the diagnosis of COVID-19: systematic review and meta-analysis. J Virol Methods 2022;300:114392.
26. Tok YT, Kuşkucu MA, Erdem H, et al. Detection of SARS-CoV-2 RNA in upper respiratory swap samples by pooling method. Balkan Med J 2022;39:48-54
27. Yilmaz SS, Kuşkucu MA, Sarıbal D, et al. Real-life experience: sensitivity and specificity of nasal and saliva samples for COVID-19 diagnosis. Ir J Med Sci 2022;191:2201-2206.
28. Cho SY, Lee DG, Kim M. Correction to: analytical and clinical performance of droplet digital pcr in the detection and quantification of SARS-CoV-2. Mol Diagn Ther 2021;25:811.
29. Chattopadhyay A, Lu T-P, Shih C-Y, Lai L-C, Tsai M-H, Chuang EY. COVID-19: Variant screening, an important step towards precision epidemiology. bioRxiv [Internet]. 2020 Oct 19 [cited
2021 May 14];2020.10.19.345140. Available from: https://doi.org/10.1101/2020.10.19.345140
30. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb
22;395(10224):565–74.
31. Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health Available from: https://www.who.int/publications/i/item/9789240018440
32. ECDC. [Type here] Sequencing of SARS-CoV-2: first update [Internet]. 2021 [cited 2021 May 14]. Available from: https://cov-lineages.org